Diabetes Foundation, India   Report issue

Foundation Phase 4
Founded: New Dehli India

Organization Overview

First Clinical Trial
2009
NCT02027740
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Diabetes Foundation, India | National Diabetes Obesity and Cholesterol Foundation

Active Ingredients

Drugs in Phase 4 Trials (1)

sitagliptin (januvia) (1 trial)

Drugs in Other Trials (5)

almond (3 trials)

cinnamon (1 trial)

mango (1 trial)

metformin (glucophage) (1 trial)

vitamin d3 (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 6